nodes	percent_of_prediction	percent_of_DWPC	metapath
LULICONAZOLE—Tinea cruris—Imiquimod—skin cancer	0.251	0.962	CcSEcCtD
LULICONAZOLE—CYP2C19—Vismodegib—skin cancer	0.218	0.295	CbGbCtD
LULICONAZOLE—CYP3A4—Temozolomide—skin cancer	0.152	0.206	CbGbCtD
LULICONAZOLE—CYP3A4—Imiquimod—skin cancer	0.152	0.206	CbGbCtD
LULICONAZOLE—CYP3A4—Vismodegib—skin cancer	0.105	0.143	CbGbCtD
LULICONAZOLE—CYP3A4—Vemurafenib—skin cancer	0.0833	0.113	CbGbCtD
LULICONAZOLE—CYP3A4—Docetaxel—skin cancer	0.0286	0.0387	CbGbCtD
LULICONAZOLE—Cellulitis—Fluorouracil—skin cancer	0.00527	0.0202	CcSEcCtD
LULICONAZOLE—Dermatitis contact—Fluorouracil—skin cancer	0.00474	0.0182	CcSEcCtD
